FDA Seeks Injunction Against Utah Medical Device Manufacturer

Article

The Food and Drug Administration (FDA), announced that it is asking to permanently enjoin Utah Medical Products, Inc. (Utah Medical), of Midvale, Utah , from manufacturing and distributing medical devices until the firm has demonstrated that it has corrected deviations from Current Good Manufacturing Practice, as set forth in the quality system regulation. The quality system regulation establishes requirements for the methods, facilities, and controls used in the production of medical devices. Utah Medical manufactures a variety of medical devices used in obstetrics, gynecology, neonatal intensive care, urology, electro-surgery, and blood pressure monitoring.

Failure to comply with the Quality System regulation does not necessarily mean that a particular device will be defective, but a firm's failure to comply with the regulation decreases the level of assurance that its products are safe and effective. "FDA will not tolerate manufacturing practices that can potentially put patients at risk," said FDA acting commissioner Dr. Lester M. Crawford. "Patients have a right to expect that the medical devices used to treat them are safe and effective."

The government's complaint was filed by the United States Department of Justice in the U.S. District Court for the District of Utah. In addition to Utah Medical, the complaint names as defendants Kevin L. Cornwell, the chairman and chief executive officer, and Ben D. Shirley, the quality manager and vice president of engineering.

The government took this action after a series of FDA inspections over the past three years revealed a pattern of significant deviations from the quality system regulation at Utah Medical's Midvale facility. During the most recent inspection, conducted between February 3 and March 3, 2004 , FDA investigators found a variety of problems, including the failure to establish that manufacturing processes were adequately controlled, and the failure to have an effective system to identify and correct manufacturing problems.

Despite repeated warnings from the FDA, including a warning letter following one of the inspections, Utah Medical has consistently failed to ensure that its products are manufactured in accordance with the quality system regulation.

 

Source: FDA

Recent Videos
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Related Content